PATENT CLAIM ANALYSIS

Application Number: 16202072
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["546", "113000"]

Abstract:
The present invention relates generally to compositions and methods for treating cancer and neoplastic disease. Provided herein are substituted pyrrolopyridine derivative compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for inhibition of histone demethylase. Furthermore, the subject compounds and compositions are useful for the treatment of cancer, such as prostate cancer, breast cancer, bladder cancer, lung cancer and/or melanoma and the like.

Claim (Index 57):
The compound of  claim 6 , wherein X is \u2014SO 2 \u2014 and R 2  is aryl.

Metadata:
- Claim Count in Document: 160.0
- Percentile: 98.0
- Lexical Diversity: 1.75
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15652174', '14774329', '14134989', '14592830', '16024452']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7802623215985081
- 35 USC 102 Novelty (BERT): 0.5333427194340299
- Combined Prediction Score: 0.7555703613820602
- Mean Citation Score: 308.315942
- Max Citation Score: 325.2463
- Similarity Product: 169.92588906692268

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test